PharmaTher Holdings Ltd.
Canadian Securities ExchangeTotal Valuation
PharmaTher Holdings Ltd. carries a market capitalization of 5.01M, placing it among publicly traded companies globally.
| Market Cap | 5.01M |
| Enterprise Value | N/A |
Share Statistics
PharmaTher Holdings Ltd. currently has 88.52M shares outstanding.
| Shares Outstanding | 88.52M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -5.27 |
| P/TBV Ratio | 14.86 |
| P/FCF Ratio | -11.12 |
| P/OCF Ratio | -11.12 |
Financial Position
PharmaTher Holdings Ltd. maintains a current ratio of 4.36, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.36 |
| Quick Ratio | 4.36 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -72.03 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
PharmaTher Holdings Ltd.'s stock has declined approximately -87.5% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.10.
| Beta (5Y) | N/A |
| 52-Week Price Change | -87.5% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.10 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -1.45M, while operating income came in at -1.45M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -1.45M |
| Pretax Income | -1.48M |
| Net Income | -1.48M |
| EBITDA | -1.45M |
| EBIT | -1.45M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Total book value stands at -3.44M, with working capital of 1.01M providing operational flexibility.
| Cash & Cash Equivalents | 1.29M |
| Total Debt | N/A |
| Net Debt | -1.23M |
| Equity (Book Value) | -3.44M |
| Book Value Per Share | -0.04 |
| Working Capital | 1.01M |
Cash Flow
PharmaTher Holdings Ltd. produced -1.63M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.63M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.63M |
| FCF Per Share | -0.02 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | -9.00 |
Scores
PharmaTher Holdings Ltd. posts an Altman Z-Score of 22.86, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 22.86 |